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Rheumatoid arthritis (RA) is a chronic inflammatory disease of unknown etiology that 
predominantly affects joints. Beside joint involvement, systemic manifestations of the 
disease are known. 
The small cricoarytenoid joints in the larynx may be involved in the arthritic process. In 
order to assess the prevalence of laryngeal involvement in patients with RA and the 
occurrence of extrathoracic airway obstruction, 29 female patients with definite or 
classical RA and 30 controls were studied. Physical examination including direct 
fiberoptic laryngoscopy, respiratory function tests and low voltage radiography were 
used. The physical examination revealed laryngeal involvement in 17 RA patients (59%), 
extrathoracic airway obstruction was indicated by spirometry in 4 patients (14%) and 
radiography revealed obvious pathological findings in 3 patients (10%). In the control 
group no subject had any finding indicating laryngeal involvement. 
The same group of RA patients were also studied regarding symptoms and signs of 
oral and swallowing disorders by means of a questionnaire, physical examination, 
stimulated saliva secretion and esophageal manometry. Subjective symptoms related to 
swallowing and dry mouth were reported four times more often by the RA patients than 
the controls. Xerostomia was associated with decreased stimulated saliva secretion. The 
amplitude of the peristaltic pressure complex in the proximal part of the esophagus was 
significantly decreased in the RA group. 
In order to find a noninvasive method of assessing a laryngeal obstruction, the 
narrowest area of a short constriction of a plastic tube was calculated by means of 
computed tomography. The obtained area was compared with the airflow resistance, 
assessed by flow-pressure measurements. The same methods were applied to 12 patients 
with laryngeal obstructions of varying origin. High correlations (model, r=1.0; patients, 
r=0.85) were found in both cases. 
Long-term results of a simple laterofixation procedure introduced in the late 1970s in 
Göteborg were evaluated in 11 consecutive patients with bilateral vocal cord paralysis. 
The improvement of breathing obtained with the operation in most cases was shown to be 
longlasting. At the follow-up assessment, 9 patients were improved and 2 deteriorated 
compared to the preoperative situation. The voice quality did not change during the years 
after operation and most of the voices were judged socially acceptable by listening panels. 
No aspiration problems were evoked by the operation. 
A modified laterofixation procedure, applied to RA patients with laryngeal ankylosis, 
was presented and documented. The procedure included mobilization of the arytenoid 
cartilages followed by laterofixation of one vocal cord. Five out of 6 operated patients 
were improved. Four of 5 patients with tracheostomas preoperatively were decannulated 
within 14 days postoperatively. The 5 patients without cannulas had acceptable voices 
postoperatively. No patient developed aspiration problems. 
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ABBREVIATIONS 
Frequently used abbreviations. 
CT Computed tomography 
Deo Lung diffusing capacity for carbon monoxide 
EEVl Forced expiratory volume in one second 
FIVi Forced inspiratory volume in one second 
FOV Field of view 
G Conductance 
HU Hounsfield Units 
Ig Immunoglobulin 
kPa Kilopascal 
AN2 The slope of the alveolar plateau with the nitrogen test 
PEF Peak expiratory flow 
PIF Peak inspiratory flow 
RA Rheumatoid arthritis 
ROI Region of interest 
Roi Resistance of the orolaryngeal airway 
Rrs Resistance of the respiratory system 
SAVS Stand alone viewing system 
SEM Standard error of mean 
VC Vital capacity 
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INTRODUCTION 
A few patients with rheumatoid arthritis (RA) presented at our emergency unit with 
severe breathing difficulties. Further investigation revealed that the dyspnea was due to 
arthritis of the cricoarytenoid joints leading to laryngeal ankylosis. These cases evoked 
our interest in the problems concerning laryngeal involvement in RA and prompted 
further studies. 
In the clinical setting, many RA patients reported problems associated with the upper 
aero-digestive tract, e.g. voice problems, dysphagia and dry mouth. A pilot study was 
carried out in order to evaluate the frequency of problems related to the larynx and the 
oral cavity (1). The study revealed that many RA patients had symptoms and signs related 
to breathing, voice and swallowing. 
An airway obstruction due to laryngeal disease may be serious and even life-
threatening. It is important to analyse objectively any method proposed for treatment of 
laryngeal obstructions. However, objective documentation has often been lacking. This 
may depend on the difficulties connected with quantification of upper airway 
obstructions. In this thesis, an invasive method for assessing the orolaryngeal resistance 
(Rol) is used as a reference method. The method is applied to evaluate the long-term 
results of a simple surgical treatment of bilateral vocal cord paralysis. It is also applied to 
document a new mobilization and laterofixation procedure for cricoarytenoid ankylosis in 
RA. However, there is a potential hazard inherent in tracheal punctures. We therefore 
continuously seek and evaluate noninvasive methods, e.g. assessment of the horizontal 
area of an obstruction by computed tomography (CT). 
Rheumatoid arthritis 
Etiology 
The etiology of RA is not known despite substantial research efforts (2). A 
multifactorial etiology has been proposed with activation of the immune system by an 
external unknown factor, e.g. a Yersinia infection, which, in predisposed individuals, 
would start a chronic rheumatic inflammation (3). 
Prevalence 
The prevalence of RA is approximately 1% (4). The prevalence has earlier been 
thought to be 2 to 4% (4, 5) and it has been proposed that it may be decreasing (4). 
Methodological differences make the interpretation of different epidemiological studies 
difficult. Women are affected three times more frequently than men (5,6) and the mean 
age of onset is 40 years (6). 
Signs and symptoms 
Since the etiology is not known, the diagnosis of RA is based on criteria, where a 
defined number of clinical signs must be present. Those criteria presented by the 
American Rheumatism Association (ARA) in 1958 (Table 1) are the most frequently used 
(7). The diagnosis of definite RA requires 5 of the 11 criteria, while the diagnosis of 
classical RA requires 7 of the criteria. The criteria were revised in 1987, the total number 
of criteria being reduced to 7, e.g. all histological criteria were withdrawn. Rheumatoid 
arthritis is defined by the presence of 4 or more criteria, and no further qualifications 
(classical or definite) (8,9). 
RA usually starts quietly with peripheral and symmetrical polyarthritis. Most patients 
are positive for rheumatoid factor and have radiographic changes like usures in their 
joints with deformity. Although the joint manifestations are dominating, a large number 
of extra-articular changes have also been reported. The rheumatic nodules are probably 
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best known but, for example pulmonary, ocular, cardiac, spleenic, neurological, muscle 
and skin involvement have been described (10,11). 
Table 1. Criteria for the diagnosis of rheumatoid arthritis presented by the American Rheumatism 
Association in 1958. 
1. Moming stiffness. 
2. Pain on motion or tenderness in at least one joint 
3. Swelling in at least one joint. 
4. Swelling of at least one other joint. 
5. Symmetrical joint swelling with simultaneous involvement of the same joint on both sides of the 
body. Terminal phalangeal joint involvement will not satisfy this criterion. 
6. Subcutaneous nodules over bony prominences, on extensor surfaces or in juxta-articular regions. 
7. X-ray changes typical of rheumatoid arthritis. 
8. Positive agglutination test - demonstration of the "rheumatoid factor" by any method which, in two 
laboratories, has been positive in not more than 5% of normal controls - or positive streptococcal 
agglutination test. 
9. Poor mucin precipitate from synovial fluid. 
10. Characteristic histological changes in synovial membrane with three or more of the following: 
marked villous hypertrophy; proliferation of superficial synovial cells often with palisading; marked 
infiltration of chronic inflammatory cells with tendency to form "lymphoid nodules"; deposition of 
compact fibrin, either on the surface or interstitially ; foci of cell necrosis. 
11. Characteristic histological changes in nodules showing granulomatous foci with central zones of cell 
necrosis, surrounded by proliferation fixed cells, and peripheral fibrosis and chronic inflammatory cell 
infiltration, predominantly perivascular. 
Laryngeal involvement 
Historical perspective 
Laryngeal involvement in RA was described as early as in 1880 by Mackenzie (12) but 
it was not until the 1950s, when Montgomery started his research in this field, that our 
knowledge increased more substantially. Montgomery has in several reports described 
the condition of cricoarytenoid arthritis (13-16). Several case reports have been published 
and many of them have emphasised the emergency aspect (17-25). Fatal outcomes have 
been reported (26-28). In a recent study, 4 out of 13 classical female RA patients had 
sleep apnea (29), which could be due to upper airway obstruction. 
A few systematically performed studies have been presented with prevalence figures of 
laryngeal involvement ranging from 13% to 75% depending on the definition of laryngeal 
involvement, material and methods (30-37). The frequency of RA involvement of the 
cricoarytenoid joint has in postmortem studies varied between 45 and 88% (30, 32, 38). 
A few reports concern children affected with cricoarytenoid arthritis, the youngest being 
only two years of age (39-41). Besides RA, several other diseases have been associated 
with cricoarytenoid arthritis, e.g. infections, gout, systemic lupus erythematosus and 
ankylosing spondylitis (42-45). 
PathQlQgy 
The cricoarytenoid joint is a diarthrodial modified ball and socket joint with 
complicated patterns of movement including rocking, gliding and rotatory movements of 
the arytenoid cartilage on the cricoid cartilage (46,47). The joint is histologically 
comparable with bigger joints with cartilagenous articular surfaces held in position by a 
ligamentous capsule lined by a synovial layer. The inflammatory changes start with 
synovitis leading to synovial proliferation, effusions with fibrin deposits, the formation 
of pannus on the joint surfaces, erosion of joint cartilage and end with obliteration and 
ankylosis of the joint, by fibrous or occasionally bony tissue (6, 14, 26, 27, 30, 32, 38). 
Other causes of impaired vocal cord mobility have been reported. Polymyositis of 
laryngeal muscles and degenerative changes of the peripheral nerves due to polyarteritis 
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of the vasa nervorum resulting in secondary muscular atrophy were also found besides 
cricoarytenoid arthritis in patients with RA (48, 49), 
Signs and symptoms 
In the acute phase, laryngoscopy reveals bright red swelling over the arytenoid regions 
(15, 39, 50, 51). The first symptom in the acute phase is said to be fullness in the throat 
or a feeling of tension (15). Other reported symptoms are: hoarseness, odynophagia, 
dysphagia, stridor, referred otalgia and pain when speaking or coughing (15,27, 48-52). 
In the chronic stage, a roughness and thickening of the mucosa over the arytenoids can 
be seen and fixation of the arytenoid cartilages may occur, resulting in a reduced glottic 
rima (15). During the chronic stage, the patients may have a slight hoarseness but more 
important is the symptom of dyspnea. Inspiratory stridor may be present during sleep, 
exertion and airway infections (6, 15). 
Discrepancy between symptoms and signs has been reported (30, 31, 33, 53). During 
recent years low voltage radiography (35, 54) and computed tomography (36, 55) have 
been added to the diagnostic arsenal. Both these methods have revealed a high prevalence 
of laryngeal involvement in RA patients, but also demonstrated the asymptomatic course 
in many cases. 
Treatment 
An acute exacerbation of RA with engagement of the cricoarytenoid joints should be 
treated with antiinflammatory drugs (15, 30, 32, 38, 56, 57). Local application of 
steroids by means of injection (58,59) or aerosol (60-62) has been proposed to be of 
value. The arthritic changes in the joints are probably reversible at this stage (38). 
Laryngeal ankylosis at the chronic stage has to be treated surgically. If the patient 
presents with severe airway obstruction, tracheotomy has to be performed in the acute 
phase. Patients with severe RA usually have finger deformities rendering the handling of 
a cannula difficult or even impossible. Few procedures specifically intended for treating 
cricoarytenoid ankylosis have been presented (15,63). Montgomery described a method 
in which one arytenoid cartilage was removed and the vocal cord lateralized with a steel 
suture. The operation was performed via laryngofissure, preceded by tracheotomy. 
Unfortunately, the effects of these procedures on breathing were not documented. A new 
method of laterofixation, preceded by mobilization of the arytenoid cartilages, has been 
found to relieve most patients of their breathing difficulties (paper V)(64). 
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AIMS OF THE STUDY 
The specific purpose of this study was: 
• to study laryngeal involvement in RA and the occurrence of extrathoracic airway 
obstruction (I), 
• to assess oral symptoms and swallowing difficulties in patients with RA (II), 
• to investigate whether the degree of a laryngeal obstruction could be determined 
by measuring the glottic area noninvasively by computed tomography (HI), 
• to study the long-term effects on breathing, voice quality and aspiration of a 
new method for surgical treatment of bilateral vocal cord paralysis (IV), and 
• to evaluate a modified version of the laterofixation procedure presented in paper IV 
in patients with laryngeal ankylosis due to RA (V). 
9 
MATERIAL 
Patients and controls (I, II) 
Twenty-nine rheumatoid-factor-positive female outpatients with definite or classical RA 
took part in these two studies. They were randomly selected from a register of 
139 women receiving parenteral gold treatment during 1985 at the Department of 
Rheumatology, Sahlgrenska sjukhuset. Thirty healthy, age-matched women served as 
controls. 
Model (III) 
A model made of a semi-rigid plastic tube (internal diameter 1.9 cm, length 53 cm) 
simulating the human upper airway was used. A triangular constriction, modelling the 
vocal cords, was made 19 cm from the oral end (i.e. the approximate distance from the 
lips to the vocal cords in man) by external compression. The triangle was varied from that 
simulating normal conditions to severe laryngeal obstruction. 
Patients (III) 
Twelve consecutive patients with laryngeal obstructions were included in this study 
(Table 2). Eight patients had bilateral vocal cord paralysis and 4 patients laryngeal 
ankylosis. 
Patients (IV) 
Eleven patients were included in this follow-up study. They were all operated upon 
with a laterofixation procedure according to Ejnell et al because of bilateral vocal cord 
paralysis. The investigation was made 5 to 9 years postoperatively. 
Patients (V) 
Six patients with laryngeal ankylosis due to RA were operated upon using a 
mobilization and laterofixation technique. One of them was a 25-year-old man with 
juvenile, seronegative RA. The others, 5 female patients with severe handicaps and a 
long disease duration (mean 36 years), had seropositive, classical RA. Three of the 
women were confined to wheelchairs. 
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METHODS 
Physical examination (I, II) 
The subjects' voices were judged to determine whether they were noticeably weak or if 
• phonatory air leakage was present during normal speech in a quiet room. The larynx was 
externally inspected and palpated. Tenderness during pressure on the thyroid cartilage 
was noted. Inspection of the mucous membranes of the oral cavity and the pharynx for 
signs of dryness like absence of a normal mucus layer was performed. Mouth ulcers 
were looked for. Secretion stagnation in the hypopharynx was noted. The hypopharynx 
and larynx were studied indirectly using a mirror and directly using a fiberoptic 
laryngoscope (Fujinor). The mucous membranes and the mobility of the vocal cords were 
inspected. Deviation of the larynx from the midline was noted (65). The examinations 
were performed by the same investigator (ÅG), who had no knowledge of any other test 
results at the time of the examinations. 
At the physical examination, laryngeal involvement was defined as a localised erythema 
and/or thickening of the mucosa over the arytenoids and/or impaired abduction of a vocal 
cord. 
Respiratory function (I, III, IV, V) 
Spirometry (I, IV, V) 
A volume-displacement, water-sealed spirometer (Bernstein) was used to determine 
vital capacity (VC) and forced expiratory and inspiratory volume in one second (FEV l, 
FTVi). At least three acceptable spirograms were obtained for each variable and the best 
was used in the subsequent analysis. Predicted normal VC and FEVi values were 
obtained from Berglund et al (66). 
Flow-volume curves (I) 
Peak expiratory and inspiratory flow (PEF, PIF) were determined from flow-volume 
loops obtained with a volume-displacement, rolling, sealed spirometer (Electro Med. 70) 
connected to a plotter (Hewlett-Packard 7090). The procedure was repeated until 
acceptable and reproducible recordings were obtained. 
Forced oscillation technique (I) 
The resistance of the respiratory system (Rrs) (i.e. the airways, lungs and thorax) was 
assessed using the forced oscillation technique (67). The set-up was similar to that 
described by Aronsson et al (68). Briefly described, the mouthpiece was connected to a 
loudspeaker generating a sinusoidal oscillating pressure (frequency 4 Hz). The mouth 
pressure was measured by a transducer (Validyne model DP 45-16) and the flow by a 
pneumotachograph (Fleisch no 2). From the relationship between the pressure and the 
flow oscillations, the resistance could be calculated. The set-up was calibrated with 
mechanical resistance before each measurement. 
The average Rrs in healthy women is 0.3-0.4 kPa/(l/s) (69). 
Nitrogen test (I) 
The slope of phase HI, i.e. of the alveolar plateau (AN2), was measured using the 
single-breath nitrogen method (70). This test has been claimed to be sensitive when it 
comes to detecting structural and functional changes in the small peripheral airways or 
lung parenchyma. Reference values were predicted according to Sixt et al (71). 
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Lung diffusing capacity (I) 
The lung diffusing capacity for carbon monoxide (Dco) was determined using the 
single-breath technique (Jaeger Transferscreen II) and reference values were obtained 
according to Salorinne (72). 
Orolaryngeal airway resistance (III, IV, V)  
The orolaryngeal airway resistance (Rol) was calculated from flow-pressure curves 
obtained with a set-up illustrated in Fig. 1. It was similar to that described earlier by other 
authors (73-78). Subglottic pressure was obtained by means of a catheter (Venflon 
1.4 mm outer diameter and 1.2 mm inner diameter) introduced into the trachea about 2 cm 
below the cricoid cartilage, and the pressure at the mouth opening was measured with an 
identical catheter at the mouthpiece. How was recorded with a pneumotachograph 
(Fleisch No 2). The differential pressure manometers for pressure and flow were 
identical (Elema-Schönander EMT 32). 
Flow and differential pressure signals were recorded in x-y mode on a storage 
oscilloscope (Tektronix) and photographed. Measurements were made on tracings of 
several consecutive reproducible breaths. At least two such tracings were obtained each 
time. Pressure and flow signals were calibrated at each investigation. 
Mouthpiece Pneumotachograph 
H -ni 
I ^ L 
r^n_j 
Venflon® 
Differential 
pressure transducers 
V 
Trachea 
Fig. 1. Schematic i llustration of the set-up. 
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Extrathoracic obstruction (I, III, IV, V) 
In line with previous reports, FIV \ and PIF were adopted as the most suitable 
variables for detecting extrathoracic obstructions (78, 79). For quantification of 
extrathoracic obstructions RqI was used. 
Radiography (I, III, IV) 
Low-voltage technique (I) 
The radiography of the larynx was performed on a Siemens Orbix using a low-voltage 
technique (54). A high resolution film-screen combination (Kodak MR1 film and MinR 
screen) was used. The films were taken while the patients held their breath. Remnants of 
one or both arytenoid cartilages as a sign of cartilage destruction were regarded as 
laryngeal involvement (35). 
Computed tomography (III) 
The investigation was performed on a Philips Tomoscan 310 with 3 mm, 1.5 mm 
overlapping slices through and in the same plane as the "vocal cords" of the model and 
the vocal cords of the patients. The slices were obtained with 120 kV, 200 mA, scan time 
9.6 s, FOV 90 (field of view) and convolution filter 6 (edge-enhancing filter). 
To obtain slices in the same plane as the vocal cords, the patient was placed supine 
with his or her neck extended. From a lateral scanogram of the neck, the appropriate 
angulation of the gantry was chosen. The patient was instructed to breathe calmly. 
The measurements were performed on a separate display unit (SAVS=Stand alone 
viewing system). The constricted area in the model and the glottic area in the patients 
were measured according to the findings reported by Baxter and Sorensen (80). The 
attenuation value of air is by definition -1000 HU (Hounsfield Units). The mean 
attenuation value of the "vocal cords" of the model and the vocal cords of the patients was 
obtained from a small region of interest (ROI) outlined adjacent to the free border of the 
vocal cords. In the patients, this measurement was repeated three times and the mean 
value was calculated. Thereafter, the mean attenuation value (halfway value) between that 
of the vocal cords and air was calculated and this halfway value represented the boundary 
(81, 82). Software functions (Level detect and ROI) on the S AVS were used to enhance 
the picture elements (pixels) with attenuation values below the halfway value and to 
calculate the appropriate area. The area was given in cm2 with one decimal and the 
smallest area possible to measure was 0.1 cm2, which was also the smallest difference 
possible to measure. 
Apart from the use of individual halfway values in the patients, we also calculated the 
glottic area at a fixed halfway value of -500 HU, corresponding to an attenuation value of 
the vocal cords of 0 HU. 
Aspiration documentation (IV) 
A routine hypopharynx-esophageous radiographic examination with barium contrast 
was performed. This investigation was done only at the follow-up. 
Laryngeal involvement (I) 
a) At the physical examination, laryngeal involvement was defined as a localised 
erythema and/or thickening of the mucosa over the arytenoids and/or impaired abduction 
of a vocal cord. 
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b) FlVi<2.01 and PIF<2.51/s were adopted as signs of impairment of the 
extrathoracic airways and as indirect signs of laryngeal involvement. The level was 
chosen in such a way that the specificity was above 80% (79). 
c) Regarding radiography, remnants of one or both arytenoid cartilages as a sign of 
cartilage destruction were regarded as laryngeal involvement (35). 
Questionnaire (I, II) 
Patients and controls completed a comprehensive questionnaire. Most questions related 
to symptoms, signs and consequences of their rheumatic disease. 
Laryngeal involvement (I) 
Those questions possibly associated with rheumatic laryngeal involvement are listed in 
Table 5 (page 22). Questions 1-4 relate to voice problems, 5-9 to breathing problems and 
10-13 to fullnes and pain in the throat. 
Swallowing difficulties (II) 
Questions related to esophageal symptoms, xerostomia, xerophthalmia and parotid 
gland disease are listed in Table 7 (page 24). The sections of the questionnaire relating to 
xerostomia, xerophthalmia and parotid gland disease (Table 7) were scored positive if the 
patient answered affirmatively to more than half of the questions according to 
Moutsopoulos et al (83). 
Stimulated saliva secretion (II) 
Quantitative evaluation of secretion of stimulated whole saliva was performed. Briefly, 
the subject was asked to chew paraffin and after the paraffin was softened the subject was 
asked to spit into a funnel connected to a graduated glass. The collection of saliva lasted 
for 5 min. A stimulated secretion rate of 0.7 ml/min or less was considered pathological 
(84-86). 
Histopathology of minor salivary glands (II) 
Labial salivary gland biopsy was performed through normal-appearing mucosa in the 
lower lip between the midline and the commisure (87, 88). After local anaesthesia, a 
single horizontal 1.5-2 cm incision was made through the lip mucosa. After blunt 
dissection, about five separate glands were removed and fixed in 4 % formaldehyde. 
Salivary gland specimens were embedded in paraffin, cut and stained with hematoxylin 
and eosin and examined microscopically. The area of salivary gland tissue was 
determined by means of a graticule. The degree of inflammation was determined by focus 
scoring, a method which provides a semiquantitative assessment of the inflammation 
(87). One standardized score is the number of focal inflammatory cell aggregates, 
containing 50 or more mononuclear cells, in each 4 mm2 area of salivary gland tissue. 
A focus score of at least 2/4 mm2, fullfilling proposed criteria for secondary Sjogren's 
syndrome, was required for a diagnosis of focal sialadenitis (89). 
Esophageal manometry (II) 
Pressures of the esophagus were transmitted by a nasally inserted, water-filled, 
continuously perfused catheter assembly to external pressure transducers (Triplus). These 
transducers were connected to a computer (via Synectics PC Polygraf). A writer was 
connected to the computer. 
The catheter bundle was passed naso-gastrically and the subject then assumed the 
supine position. The patient was asked to swallow 5 ml of water at room temperature 
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intermittently with an interval of approximately 25 s between swallows. The registration 
apparatus was calibrated to atmospheric pressure and to standardized hydrostatic 
pressures before and after every examination. 
All calculations were based on the results obtained from paper tracings. Amplitudes 
and durations of the peristaltic pressure complexes were analysed in the proximal 
(approximately 5 cm below the upper esophageal sphincter) and distal (approximately 
5 cm above the lower esophageal sphincter) part of the esophagus. The amplitude was the 
difference between the peak of the contraction and the precontraction baseline. The 
contraction duration was the time between the sharp upstroke of the contraction from the 
baseline and the return to the precontraction baseline. The mean values of two 
representative contractions are given. 
Repeated dry swallowing test (II) 
The patients were instructed to swallow 11 times as fast as possible and no fluids were 
given. Pressure was recorded continuously during the test. The swallowing test time was 
defined as the time between the first and last pharyngeal pressure peaks (90). 
Laboratory data (I, II) 
The erythrocyte sedimentation rate was determined and immunoglobulin class-specific 
rheumatoid factors were analysed using a diffusion-in-gel, enzyme-linked, 
immunosorbent assay technique (91,92). 
Operation (IV, V) 
Bilateral vocal cord paralysis (IV) 
The operation was performed under general anaesthesia. Two surgeons operated at the 
same time: one externally on the neck and the other via a laryngoscope using a 
microscope. The external surgeon made an incision in the skin and exposed one lamina of 
the thyroid cartilage. Two needles were inserted through the cartilage (Fig. 2), one above 
and the other below the vocal cord (Fig. 3). A nylon thread was passed through the lower 
needle and then brought out again through the upper needle, thus forming a loop around 
the vocal cord. The needles were withdrawn and the loop was tightened until the vocal 
cord was sufficiently lateralized. 
Laryngeal ankylosis (V) 
The method of laterofixation was the same as described for vocal cord paralysis (IV). 
The laterofixation was, however, preceded by a mobilization procedure by means of 
semirigid esophageal dilators passed through the glottal rima between the vocal processes 
of the arytenoid cartilages. The vocal cords thus became temporarily mobile. 
Voice quality (IV) 
Tape recordings were made on a Revox tape-recorder in a soundproof room while the 
patients read aloud from a standard text. Voice samples of one minute's duration were 
edited to make one tape. Two panels listened to the recordings. One panel consisted of 
10 people who had no previous experience of speech therapy, the amateur panel, and the 
other panel consisted of 6 speech therapists. Each member of the panel was instructed to 
evaluate each voice sample and to score it from 0 to 4 regarding timbre, tempo and 
inspiratory stridor. Each voice sample was also judged by the panels as to whether it was 
socially acceptable or not. A recorded voice was to be judged socially acceptable if the 
patient was considered to be able to perform normal daily activities like shopping, making 
telephone calls and keeping a job. 
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Oblique line 
Upper needle 
Lower needle 
Fig. 2. Insertion points of the needles in the thyroid cartilage. 
Fig. 3. Frontal projection of the larynx with the needles and the thread around the vocal cord. 
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Statistics (I, II, III, IV) . 
Student's t test for unpaired (I,II) and paired (III, IV) observations, Chi-Square test 
with continuity correction (I, II), Fisher's exact test (I, II) and Mantel-Haenszel s chi-
square test (I) were used. Sensitivity and specificity calculations were performed (I). The 
correlation coefficient (r) was determined in paper ID and the critical values for statistical 
significance were taken from Pearson and Hartley (93). Only two-tailed tests were used. 
RESULTS AND DISCUSSION 
Physical examination (I, II) 
No patient or control subject was judged to have a noticeably weak or hoarse voice or 
to have inspiratory stridor during tidal breathing or when speaking. 
Tenderness during pressure on the thyroid cartilage was reported by 6 patients (21%), 
compared with none in the control group (p<0.05). A slightly deviated larynx was found 
in one patient but in no control subject. 
On inspection, 26 of the 29 RA patients were judged to have normal mucous 
membranes in the oral cavity and the pharynx and no secretion stagnation in the 
hypopharynx. Two RA patients had dry mucous membranes in the mouth and pharynx. 
Both of them had decreased stimulated saliva secretion while only one reported 
xerostomia. One of them was treated with antidepressant and antihistamine drugs. A third 
patient showed secretion stagnation in the hypopharynx. No patient had ulcerations in the 
mucous membranes. No abnormal findings were found on examination of the control 
subjects. 
A localised erythema and/or thickening of the mucosa over the arytenoids was found in 
16 of the RA patients (55%) but in none of the control group (pcO.OOl). Impaired 
abduction of the vocal cords was observed in 5 RA patients. Two of them showed 
bilateral limitation of abduction and the remaining 3 displayed unilateral limitation. No 
subject in the control group had impaired abduction of the vocal cords. No case of 
severely impaired abduction or complete midline fixation of the vocal cords was 
observed. A vocal cord nodule was observed in one RA patient. 
On indirect mirror and direct fiberoptic laryngoscopy, the mean maximum transverse 
distance of the glottal rima was visually judged to be 10.3 ± 0.3 mm (SEM) in the RA 
group and 11.8 ± 0.2 mm in the control group (pcO.OOl). The maximum transverse 
distance of the glottal rima for the 5 RA patients with impaired abduction was shorter, 
8.2 ± 0.6 mm, compared with 10.8 ± 0.3 mm for the remaining 24 patients (pcO.Ol). 
The overall prevalence of laryngeal abnormality in the RA group, found with indirect 
mirror and/or direct fiberoptic laryngoscopy, was 59% (17/29), compared with zero in 
the control subjects (pcO.OOl). 
Routine indirect mirror laryngoscopy usually gives a good view of the arytenoid region 
and the vocal cords. Advantages of mirror investigation are the good overview and the 
clear sight with an undisturbed colour impression. However, some patients have 
enhanced swallowing reflexes or a covering epiglottis making conventional mirror 
investigation difficult or impossible. In addition, RA patients may have stiff necks and a 
reduced ability to open the mouth due to involvement of the temporomandibular joints. 
However, in this series no RA patient had any difficulties open her mouth at the mirror 
investigation. With a fiberoptic laryngoscope, it has been possible to investigate all 
patients and controls. In particular, it is a superior tool when the vocal cord motions are 
investigated. 
The physical examination revealed rheumatic laryngeal involvement in 59% of the RA 
patients in this series, which is in accordance with Lawry et al, who reported a laryngeal 
abnormality prevalence of 52% in their RA material (36). When a broader definition of 
laryngeal involvement was used, including minor disturbances of the vocal cord motions, 
a prevalence of 75% was reported (37). In postmortem studies, even higher figures have 
been reported (32). 
1 9 
All patients with tenderness during pressure on the thyroid cartilage, one of them also 
with a deviated larynx, belonged to the group of RA patients with laryngeal involvement. 
Respiratory function (I) 
The results of the Spirometrie tests reflecting the extrathoracic airways are presented in 
Table 3. A significant reduction of the forced inspiratory volume in one second and the 
peak inspiratory flow was observed in the RA group. Three patients had FIVi<2.0 1 and 
2 patients PIF<2.5 1/s. One patient had decreased values in both tests. Thus, 4 patients 
had FTVi<2.0 1 and/or PIF<2.5 1/s. No controls had FIVi<2.0 1 or PIF<2.5 1/s. 
Table 3. Spirometrie results with special reference to the extrathoracic airways in 29 RA 
patients and 30 controls (mean ± SEM). 
Test RA Controls 
FIVi G) 2.8 ±0.1* 3.3 ±0.1 
FIVi/VC (%) 85 ±2* 90 ±1 
FEVi/HVj 0.9 ±0.04 0.9 ±0.02 
PIF (1/s) 4.0 ±0.2* 5.0 ±0.3 
PEF/PÏF 1.5 ±0.1 1.5 ±0.1 
* denotes p<0.05. 
Generally, the RA group showed impaired Spirometrie values compared with the 
control group (Table 4). The resistance of the respiratory system was significantly 
elevated in the RA group. A reduction in the gas transfer ability, indicated by significantly 
reduced Dco, could also be observed. 
Table 4. Lung function test results in 29 RA patients and 30 controls (mean ± SEM). 
Test RA Controls 
VC (% pred) 102 ±3 108 ±3 
FEVi (% pred) 101 ±4 109 ±3 
FEVi/VC (% pred) 98 ±2 100 ±2 
AN2(%pred) 278 ±60 172 ±27 
Dco (% pred) 84 ±3*# 98 ±31 
PEF (1/s) 5.9 ±0.2* 7.0 ±0.3 
Rrsexp (kPa/tl/s]) 0.59 ±0.04* 0.42 ±0.031 
Rrsinsp (kPa/[l/s]) 0.40 ±0.03* 0.30 ±0.02t 
* denotes p<0.05, # denotes n=28, t denotes n=29. 
Breathing difficulties in patients with RA could be due to laryngeal involvement. 
However, several pulmonary manifestations of RA have been described, including 
pleurisy with or without effusion and interstitial fibrosis, also resulting in dyspnea 
(94-97). Although many papers dealing with RA and pulmonary function have been 
published, to our knowledge no investigation has been focused on the extrathoracic 
airways. In the present study, 4 of the RA patients (14%) had Spirometrie signs of 
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obstruction of the extrathoracic airways, i.e. presumable laryngeal obstruction (78). 
These 4 patients had normal vital capacity, forced expiratory volume and diffusing 
capacity. 
Low-voltage radiography (I) 
Small remnants of one or both arytenoid cartilages were found in 3 patients. No similar 
changes were found in the control group. One or both arytenoid cartilages were invisible 
in 8 RA patients and in 7 control subjects. One patient and one control subject were 
excluded from the investigation due to massive motion artefacts. 
The low-voltage radiography technique produced a wide variation in the degree of 
calcification and visibility of the laryngeal cartilages in both groups. The invisibility of 
one or both arytenoid cartilages in 8 RA patients could be due to total destruction. It is 
also possible that the cartilages were not calcified. A third explanation might be purely 
methodological. The cartilages were not demonstrable in 7 of the control subjects. The 
high proportion of investigations which could not be evaluated using the present 
procedure made the examination less useful. 
The results of the low-voltage radiography, with only 10% pathology and a relatively 
high number of investigations which could not be evaluated, differed markedly from 
previous reports (35, 36, 55). The reason could be partly technical. Only Jurik et al (35) 
used the low-voltage technique and, in their material, 9 of the 17 female RA patients 
showed erosions of the arytenoid cartilages when compared with a normal material of 
16 females; all of them had symmetrically calcified arytenoid cartilages with visible 
articular facets (54). It was noteworthy that only 2 of their female controls were aged 
below 50. As we used an orbix instead of mammography equipment, discrete erosions 
and faint calcifications may have been missed. Bienenstock et al (32) found RA changes 
in the cricoarytenoid joints in 7 of 8 patients with RA in postmortem studies. However, 
only one of them had a clear erosion of an arytenoid cartilage. 
Laryngeal involvement (I) 
Four patients (group A) fulfilled the criteria for laryngeal involvement in two of the 
three investigations (physical examination, spirometry and radiography). Sixteen patients 
(group B) fulfilled the criteria in one investigation. No patient fulfilled the criteria for 
laryngeal involvement in all three investigations. Thus, at least one sign of laryngeal 
involvement was found in 20 patients (69%). Nine RA patients (group C) and all the 
controls were negative. No difference in the prevalence of laryngeal involvement was 
noted among the patients who were smokers or ex-smokers compared with those who 
were non-smokers. 
Questionnaire (I, II) 
Laryngeal involvement (I) 
Table 5 shows the positive answers to 13 questions on laryngeal involvement. Patients 
with signs of laryngeal involvement (groups A and B) had more symptoms than patients 
without such signs (group C)(n.s.) and controls (pcO.OOl). Three or more of the 
13 questions in Table 5 were answered affirmatively by 3 out of 4 subjects (75%) in 
group A, 7 out of 16 (44%) in group B, 1 out of 9 (11%) in group C and 1 out of 30 
(3%) in the control group. However, no single question was answered in the affirmative 
significantly more often by patients with laryngeal involvement than by patients without 
laryngeal involvement. 
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Questions 1-4 related to voice problems. Eight of 20 patients with laryngeal 
involvement (groups A and B) answered one or more of these questions positively 
(sensitivity=40%), compared with none in group C (n.s.)(specificity=100%). 
Questions 5-9 related to breathing problems. Fifteen of the patients with laryngeal 
involvement answered one or more of these questions positively (sensitivity=75%), 
compared with 5 in group C (n.s.)(specificity=44%). 
Questions 10-13 related to fullness and pain in the throat. Eleven of the patients with 
laryngeal involvement answered one or more of these questions positively 
(sensitivity=55%), compared with 2 in group C (n.s.)(specificity=78%). 
Table 5. Thirteen questions possibly associated with rheumatic laryngeal involvement and the numbers of RA 
patients and controls giving positive answers to these questions. Groups A, B and C represent patients with two, one or 
no s igns of laryngeal involvement of the RA. 
A B C Controls 
n=4 n-16 n=9 n=30 
1. Do you have a hoarse voice? 2 3 0 1 
2. Do you have an unusually weak voice? 0 1 0 2 
3. Have you had one or more periods of hoarseness during the last 
year without having a cold? 2 3 0 0 
4. Does your throat sometimes hurt when speaking? 1 3 0 1 
5. Have you experienced difficulties breathing in at any time during 
the last year? 2 3 3 1 
6. Do you easily get short of breath in connection with moderate 
physical exercise? 3 10 3 3 
7. Do you experience breathing difficulties when you have a cold? 0 5 2 2 
8. Can a strange or wheezing sound be heard when you breathe? 0 3 0 0 
9. Can a strange or wheezing sound be heard when you speak? 1 1 0 0 
10. Does your throat sometimes hurt when you cough or clear your 
throat? 1 2 1 0 
11. Do you sometimes have earache without having a cold? 2 5 1 2 
12. Do you often have a feeling of fullness in your throat? 2 4 1 1 
13. Does it sometimes hurt when you swallow? 3 3 1 0 
Positive answers/n 4 . 8  2 . 9  1 . 3  0 . 4  
The mean age of the patients in the three RA subgroups did not differ significantly 
(Table 6). A longer disease duration, though not significantly, was found in patients with 
laryngeal involvement compared with patients without laryngeal involvement (Table 6). 
The functional class of the patients according to the American Rheumatism Association 
can be seen in the same table. A tendency towards more severe RA disease was observed 
among patients with laryngeal involvement compared with those without laryngeal 
involvement (n.s.). 
Questions relating to breathing difficulties had relatively high sensitivity in this study 
when it came to laryngeal involvement in an RA population but their specificity was low. 
Questions relating to the voice had high specificity but low sensitivity. 
Our findings are in accordance with Lawry et al, who reported that inspiratory 
difficulties had predictive value (36). Other authors found hoarseness (32, 37) or the 
sensation of a foreign body (31) to be the most common symptoms. 
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Table 6. Mean age (years), disease duration (years) and functional class (% of n) of RA patients with 
two (group A), one (group B) or no (group C) signs of laryngeal involvement (mean ± SEM). 
A 
n=4 
B 
n=16 
C 
n=9 
Age 63+1.6 53+2.4 55±1.5 
Disease duration 15±1.8 17±2.3 11±2.2 
Functional class 1 0 6 33 
n 50 50 44 
m 50 44 22 
It should be noted that patients with laryngeal involvement could be asymptomatic. On 
the other hand, some patients without laryngeal involvement reported symptoms. 
The questionnaire was not able accurately to distinguish all the RA patients with 
laryngeal involvement from patients without laryngeal involvement. However, by 
questioning the patient, suspicion of laryngeal involvement could arise and the patient 
could then be referred for further investigation. 
There was a tendency towards more severe disease in patients with laryngeal 
involvement which is in accordance with a previous report (37). However, in another 
study, no correlation was found between disease severity and laryngeal involvement 
(33). 
Swallowing difficulties (II) 
Subjective symptoms related to the esophagus (except the question regarding heartburn 
or acid reflux) and xerostomia (Table 7) were reported by 83% of the RA patients 
(controls 20%, pcO.OOl). 
The answers to the questions relating to esophageal symptoms revealed that dysphagia 
(question no 1), odynophagia (question no 2) and troublesome heartburn or acid reflux 
(question no 4) were experienced significantly more frequent among the RA patients than 
among the control subjects (Fig. 4). 
The answers to the questions relating to xerostomia and xerophthalmia are presented in 
Fig. 4. Six patients in the RA group had >5 positive answers in the group of questions 
relating to xerostomia. Xerophthalmia was reported by 5 patients. In addition, 2 patients 
had a history of parotid gland disease. None of the controls had xerostomia, 
xerophthalmia or parotid gland disease according to the questionnaire. 
Of the 6 patients with xerostomia, 4 had decreased stimulated saliva secretion 
(<0.7 ml/min), compared with 2 of the remaining 23 patients (p<0.05). One patient with 
xerostomia reported both dysphagia and odynophagia and another patient odynophagia. 
The remaining 4 patients reported no swallowing dysfunction symptoms. 
Patients with xerostomia did not differ significantly from patients without xerostomia 
in terms of age or disease duration. 
One of the 6 patients with xerostomia used drugs that could decrease saliva secretion; 
she took both antidepressant and antihistamine drugs. Another RA patient was taking an 
antidepressant drug. No control subject took drugs known to cause xerostomia. 
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Table 7. Questionnaire for the assessment of some esophageal symptoms, xerostomia, 
xerophthalmia and parotid gland disease. 
Esophageal symptoms 
1. Do you sometimes have difficulties swallowing solid food? 
2. Does it sometimes hurt when you swallow? 
3. Do you often have a feeling of a lump in your throat? 
4. Are you troubled by heartburn or acid reflux? 
Xerostomia 
1. Do you drink lots of fluids with your meals? 
2. Does food stick in your mouth or throat? 
3. Can you eat a dry cracker without water?* 
4. Has your sense of taste changed? 
5. Do you keep a glass of water at your bedside at night? 
6. Do you wake up at night because you have a dry mouth? 
7. Do you carry a bottle of water with you? 
8. Does your mouth feel dry? 
9. Do you have excessive dental cavities? 
Xerophthalmia 
1. Do you often feel a "sandy" sensation in your eyes? 
2. Are your eyes frequently red? 
3. Are your eyes often irritated in another way? 
4. Do you have excessive matter in your eyes in the morning? 
5. Do your eyelids stick together in the morning? 
6. Have you noticed a decreased amount of tears when you cry? 
7. Are your eyes dry? 
8. Do you have frequent eye infections? 
9. Do you use artificial tears? 
Parotid gland disease 
1. Have you had mumps as an adult? 
2. Have you had mumps more than once? 
3. Have you had intermittent swelling of your parotid glands (in front of the ears)? 
* A "no" answer is considered positive. 
Eleven RA patients belonged to functional class III. Their mean disease duration was 
16 ± 2.5 years. Seven of them had or had previously had rheumatic nodules on their 
elbows. None of them took antidepressant or antihistamine drugs. These 11 patients were 
compared with the remaining 18 RA patients in functional class I or II (mean disease 
duration 14 ± 1.9 years) regarding dysphagia, odynophagia, feelings of a lump in the 
throat, heartburn and xerostomia. Only regarding dysphagia was a significant difference 
found. Six patients (55%) in functional class IH reported dysphagia, compared with 
2 of the patients (11%) in lower functional classes (p<0.05). 
Our finding of dysphagia in 28% of patients could be compared with a study by Doig 
et al (98). They reported dysphagia in 10% of RA patients without signs of Sjogren's 
syndrome and in 32% of RA patients with Sjogren's syndrome. Severity of the RA 
disease was associated with dysphagia in the present study, whereas decreased stimulated 
saliva secretion was not Patients with dysphagia did not differ significantly from patients 
without dysphagia in terms of age or disease duration. 
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Fig. 4 .Positive answers in per cent to questions relating to esophageal symptoms, xerostomia and 
xerophthalmia among 29 patients with rheumatoid arthritis and 30 healthy controls. The numbers refer to 
the questions in Table 7 (* denotes p<0.05). 
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Five RA patients (17%) and one of the controls (3%) had complete dentures. Three of 
the patients had dentures in both the upper and lower jaw. Only one of the patients with 
dentures had dysphagia. One patient with complete dentures reported both xerostomia 
and odynophagia. None had a decreased stimulated saliva secretion. However, 5 of 
6 patients with excessive dental cavities had xerostomia (p<0.001) and 4 of them also 
decreased stimulated saliva secretion (p<0.05); the comparisons relate to the remaining 
23 patients without excessive dental cavities. 
Stimulated saliva secretion (II) 
The mean stimulated saliva secretion in the RA group was 1.5 ± 0.1 (SEM) ml/min, 
compared with 1.7 ± 0.1 ml/min in the control group (n.s.). In the RA group, 6 subjects 
had a stimulated secretion rate of 0.7 ml/min or less, compared with 2 of the controls. 
Four of the 6 patients with decreased saliva secretion reported xerostomia, compared with 
2 of the remaining 23 patients (p<0.05). The 6 patients with decreased saliva secretion 
had no significant increase in swallowing dysfunction symptoms. One of the 2 control 
subjects with decreased saliva secretion was one year after the test found to have a 
chronic inflammation of her left parotid gland. One of the RA patients with reduced saliva 
secretion was taking antidepressant and antihistamine drugs. 
More patients with RA had complete dentures and dental cavities than the controls. 
Both the difficulty in maintaining optimal oral hygiene and a decreased salivary flow 
make a rheumatic patient prone to develop oral and in particular dental problems (99). 
Histopathology of minor salivary glands (II) 
The subjects with 0.7 ml/min or less stimulated saliva production were invited to a 
further examination with labial salivary gland biopsy. Four out of 6 RA patients agreed to 
performance of labial biopsies and focal sialadenitis was recorded in all. The 2 control 
subjects with reduced saliva secretion did not want to extend the examination. 
Three of our patients (10%) reported both xerostomia and xerophthalmia and 8 (28%) 
reported at least one of these symptoms. All 4 patients who underwent labial biopsy had 
focus scores indicative of Sjogren's syndrome. In earlier reports, secondary Sjogren's 
syndrome has been reported in 10 to 30% of patients with RA (6, 100-102). 
Xerostomia was reported by 6 RA patients (21%) in this study. This prevalence is in 
accordance with an earlier report of xerostomia in 17% of an RA group (102). Four of 
6 patients with xerostomia had no swallowing complaints. A previous report has shown 
that the correlation between saliva secretion and a subjective feeling of diy mouth is weak 
(102). In this study, we found that xerostomia was associated with decreased stimulated 
saliva secretion. The decreased secretion was probably due to sialadenitis. 
Esophageal manometry (II) 
Twenty-eight of the RA patients agreed to participate in this investigation.The tracing 
of one patient was lost due to a technical error but both her manometric recording and the 
repeated dry swallowing test were normal as judged on the screen at the investigation. 
Seventeen subjects in the control group were invited to perform the esophageal 
manometry and the repeated dry swallowing test, and they all accepted. 
The results of the motility measurements regarding contraction amplitude and duration in 
the proximal and distal part of the esophagus are shown in Table 8. The amplitude of the 
peristaltic pressure complex in the proximal part of the esophagus was significantly 
decreased in the RA group compared with normal controls. No significant difference was 
found in the distal part of the esophagus. The 2 patients taking antidepressant drugs (one 
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of them also an antihistamine) had amplitudes in the proximal part of the esophagus 
above the mean value of the RA group (33 and 35 mmHg, respectively). 
Table 8. Amplitude and duration of peristaltic contractions in the proximal and distal part of the 
esophagus in 27 RA patients and 17 control subjects (mean ±SEM). 
Motility RA Controls 
Amplitude proximal part (mm Hg) 32 ±2* 45 ±7 
Duration proximal part (s) 2.1 ±0.1 2.5 ±0.2 
Amplitude distal part (mm Hg) 53 +4 61 ±6 
Duration distal part (s) 3.6 ±0.1 3.4 ±0.3 
* denotes p<0.05 
Coordination between the pharynx and the upper esophageal sphincter and peristaltic 
muscular activity in the whole esophagus were found in 27 RA patients and in all control 
subjects. Unspecific changes with some segmental contractions alternating with normal 
muscular activity were found in one RA patient. This patient was the one with secretion 
stagnation in the hypopharynx. However, she had no subjective swallowing problems. 
Esophageal manometry revealed that the amplitude of the peristaltic pressure complex 
in the proximal part of the esophagus in RA patients was significantly reduced compared 
with the controls, indicating dysfunction of die striated muscles. This finding is in 
accordance with two previous reports (103,104). In one of these a few cases with distal 
esophageal dysfunction were also reported (103). No controls were used in these two 
studies. Other investigators have failed to find esophageal dysfunction in RA patients 
(105, 106). However, in one of the studies only the distal smooth muscle part of the 
esophagus was examined and the other study was purely radiographic. 
A slight reduction of the contraction amplitude was also seen in the lower part of the 
esophagus in this study, although this was not statistically significant. However, no 
signs of specific changes in the lower part of the esophagus, like those seen in 
sclerodermia, were found. Tsianos et al found one out of 25 RA patients with lower 
esophageal hypomotility (107). The RA patients in the present study with low contraction 
amplitudes (<25 mm Hg, n=9) in the upper esophagus showed no significant increase in 
symptoms of dysphagia, odynophagia, a feeling of a lump in the throat or xerostomia. 
Only one of the patients with low amplitude had subnormal stimulated saliva secretion. 
Myopathy and/or neuropathy due to the RA disease and/or a side-effect of drugs might be 
a mechanism explaining the impaired esophageal muscular function found in this study 
(11,108-111). The reduction of the contraction amplitudes seemed not to be of such 
magnitude that it evoked esophageal symptoms. 
In patients with primary Sjogren's syndrome and systemic lupus erythematosus, 
absent or low contractions in the upper third of the esophagus have been reported (112, 
113). In another study of patients with primary and secondary Sjogren's syndrome, 
however, no evidence of esophageal motility disturbance as a cause of dysphagia was 
found; instead, the authors favoured the opinion that dysphagia was secondary to 
xerostomia (114). The same opinion was stated by the authors of a paper reporting 
mucosal atrophy in the esophagus in patients with primary and secondary Sjogren's 
syndrome (115). In our study of RA patients no significant association between 
xerostomia or decreased stimulated saliva secretion and dysphagia was found. 
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Repeated dry swallowing test (II) 
Twenty-seven patients and 17 controls performed this test accurately. The mean 
swallowing test time for the RA group was 50 ± 4 s (range 20-93 s), compared with 
55 ± 5 s (range 22-92 s) in the control group (n.s.). 
At this test no RA patient was found to have a prolonged swallowing test time 
compared to normal controls, suggesting that necessary saliva and normal receptor 
function were present (90, 116). 
Arthritis of the temporomandibular joints has been reported in one-third to two-thirds 
of RA patients (99, 117,118). Reported symptoms related to the chewing ability. 
Pharyngeal dysfunction registered cineradiographically has been reported to be more 
common in RA patients with decreased ramal height of the mandible compared with 
patients with a normal mandible (119). In the same study, pharyngeal dysfunction was 
shown to be more common in RA patients with vertical dislocation of the cervical spine 
compared with patients with a normal cervical spine. However, the authors found about 
the same degree of pharyngeal abnormalities during cineradiography in non-dysphagial 
patients as in dysphagial patients. This illustrates the complexity of dysphagia regarding 
correlation of objective findings and symptoms. 
We conclude that xerostomia and dysphagia are common among RA patients. 
Xerostomia was, as expected, associated with low stimulated saliva secretion, 
presumably due to sialadenitis. Dysphagia in RA patients may be due to several 
mechanisms such as rheumatic cervical involvement, arthritis of the temporomandibular 
joints, decreased amounts of saliva, teeth problems, pharyngeal dysfunction, laryngeal 
involvement and esophageal muscular dysfunction. In this study dysphagia could be 
significantly correlated only to the severity of the RA disease. 
Laboratory data (I, II) 
The values of erythrocyte sedimentation rate and of all class-specific rheumatoid factors 
were significantly higher (pcO.OOl) in the RA group (Table 9) than in the controls. 
The 11 RA patients belonging to functional class III were compared with the remaining 
18 RA patients in functional class I or II regarding erythrocyte sedimentation rate and 
class-specific rheumatoid factors. A statistically significant difference (p<0.05) was 
found only regarding IgG. The mean value for the 11 patients in functional class III was 
8.6 ±1.0 mm, compared with 4.7 ± 1.1 mm for the patients in lower functional classes. 
No significant differences in erythrocyte sedimentation rate and class-specific 
rheumatoid factors were found between RA patients with and without laryngeal 
involvement. 
Table 9. Erythrocyte sedimentation rate (ESR) and class-specific rheumatoid factors (RF) 
(mean ± SEM) in the RA group (n=29) and the control group (n=30). 
RA Controls 
ESR (mm) 34+4.5* 11±2.0 
IgG RF (mm) 6.3+0.8* 1.3±0.5 
IgA RF (mm) 8.0±0.9* 0.5±0.3 
IgM RF (mm) 9.9±0.5* 3.7±0.6 
* denotes p<0.001. 
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Patients with dysphagia and xerostomia respectively were compared with patients 
without dysphagia or xerostomia regarding erythrocyte sedimentation rate and class-
specific rheumatoid factors. No significant differences were found in these comparisons. 
Orolaryngeal airway resistance and computed tomography (III) 
The calculated areas and the airflow resistances in the model are presented in 
Table 10 and illustrated in Fig. 5. The relationship is consistent with a curvilinear 
relationship. 
Table 10. Area and airflow resistance of the model. 
Area fem2) R fldPa/O/stt 
0.2 0.56 
0.3 0.39 
0.3 0.32 
0.4 0.11 
0.5 0.09 
0.9 0.02 
0,6 
0,4 -
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Fig. 5. Correlation between the airflow resistance and the area in the model. 
The glottic areas in the patients are calculated both from their individual halfway values 
and from a fixed halfway value (-500 HU)(Table 2, page 11). The relationship between 
R01 and the CT-determined area measured with individual halfway values is shown in 
Fig. 6. In this diagram, too, the relationship is consistent with a curvilinear relationship. 
The Rqj values among the patients vary from 0.1 to 1.2 kPa/(l/s), i. e. from that of a 
normal larynx to a severe laryngeal obstruction (78). 
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Fig. 6. Correlation between the orolaryngeal airway resistance and the glottic area. 
Determinations of Rol in patients have shown good agreement with clinical findings 
and repeated determinations of Rol on different occasions have given similar results 
(120). We consider Rol to be the best available method for quantifying a laryngeal 
obstruction. However, determination of Rol is an invasive method, which limits its 
usefulness. This method is not suitable for patients with bleeding disorders and small 
children. 
Computed tomography is noninvasive and the equipment is widespread. In this study, 
it seemed possible to calculate the glottic area by means of CT. However, some 
difficulties arose, e.g. some patients were not able to lie supine with their neck extended 
or had breathing problems in this position. Due to the long scanning time (9.6 s) motion 
artefacts occurred. The boundary between an object and its background is best 
represented by the halfway value between the attenuation value of the object and the 
background (80-82). In the model, it turned out to be simple to decide this halfway value, 
but in man it was rather difficult, despite the use of a narrow window and an edge-
enhancing filter. It was also possible to use a fixed halfway value between that of soft 
tissue and air, which facilitates the calculations. 
Air passing a human larynx is subjected to a complex flow pattern. Jaeger & Matthys 
found, in a thorough study (121), that the flow pattern was similar to that existing in a 
Ventmimeter. Thus, during very low flow rates the flow pattern is laminar and during 
very high flow rates the flow pattern has the character of orifice flow. In a wide interval 
between these flow patterns, the flow pattern cannot be expressed in a simple algebraic 
equation. When calculating Reynolds' number in the patients and in the model, it was 
found to be within the interval of 3 500 and 11 000. According to Jaeger's & Matthys' 
findings, the conductance (G=l/R) should then most likely be proportional to the second 
power of the area. Applied to the model, we found a very high coefficient of correlation 
(r=1.00) between G and the second power of the area. It thus seemed possible to assess 
an obstruction with CT under ideal circumstances. The corresponding coefficient of 
correlation among the patients was slightly lower (r=0.85). Measuring the area with fixed 
halfway values gave only a somewhat lower coefficient of correlation. The correlation 
coefficients regarding both the model and the patients were statistically significant 
(p<0.001). 
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An attempt to measure the length of the obstruction was made. Since all patients had 
diseases of the vocal cords, the obstructions were short, but still difficult to measure. 
Adding length to the calculations did not enhance the correlation coefficient. 
The results of this study indicate that it is possible to measure the narrowest area of a 
short constriction by CT. Patients with Rol values over 0.2 kPa/(l/s) usually have 
symptoms of upper airway obstruction, while patients with Rol values below 
0.2 kPa/(l/s) do not (120). In the present study all patients with glottal areas of 0.4 cm2 
or less had a Rol value of 0.3 kPa/(l/s) or higher. The results of this limited series 
indicate that it is possible to detect a laryngeal obstruction by CT and that it is possible to 
some extent to quantify the obstruction. Difficulties were, however, encountered, 
especially when measuring the narrowest obstructed areas. 
Long-term results of lateroflxation (IV) 
Breathing 
The patients were investigated preoperatively and postoperatively for the first time after 
a mean of 1.4 months (range 0-4). The follow-up measurements were performed on 
average 7.3 years (range 5-9) postoperatively. Rol could be determined in all patients 
(Table 11). 
Table 11. Individual data and upper airway resistance (R0i)for 11 patients with bilateral vocal cord 
paralysis operated upon with the lateroflxation procedure. 
No Sex 
Follow-up age Rol (kPa/(l/s)) 
(years) Pre-op Post-op Follow-up 
1 M 46 0.7 0.6 0.4 
2 M 60 0.6 0.1 0.1 
3 F 63 0.9 0.8 0.7 
4 F 63 0.8 0.4 0.6 
5 F 64 0.4 0.4 0.6 
6 F 65 0.9 0.4 0.2 
7 M 67 0.7 0.7 0.3 
8 F 68 0.4 0.4 0.5 
9 F 71 0.6 0.2 0.3 
10 M 71 0.4 0.5 0.2 
11 F 73 1.1 0.6 0.4 
Preoperatively, the mean orolaryngeal resistance was 0.66 ± 0.07 kPa/(l/s)(SEM). 
Postoperatively it decreased to 0.45 ± 0.06 kPa/(l/s) and at the follow-up assessment it 
was 0.39 ± 0.06 kPa/(l/s) (Fig. 7). The decrease between the postoperative and the 
follow-up value was not significant. The improved breathing capacity was unchanged 
during the postoperative follow-up period. The decrease of Rol between preoperative and 
early postoperative values was significant (p<0.05). The decrease of Rol was significant 
also when comparing preoperative values with the follow-up results (pcO.Ol). Seven 
patients had improved Rol at the postoperative assessment, 3 were unchanged and one 
deteriorated. At the follow-up assessment, 9 patients were improved and 2 deteriorated 
compared to the preoperative situation. 
Rol is approximately 0.1 kPa/(l/s) in normal humans (78). Our patients varied from 
moderate to severe laryngeal obstruction. Two patients had not improved at the follow-
up. These 2 patients had only a slightly increased R0i. (0.4 kPa/[l/s]) preoperatively. 
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They had only moderate stridor during exertion both pre and postoperatively and they 
were not severely disabled. Their symptoms were not considered severe enough to 
indicate a more complicated operation. In our experience, a patient with a Rol of less than 
0.5 kPa/(l/s) is not usually a candidate for the laterofixation procedure. Thus, in our 
opinion, determination of RqI is useful because the degree of laryngeal obstruction can 
be objectively assessed, which allows improved selection of patients for the operation 
and contributes to the evaluation of the results. 
0,8 -i 
Pre-op Post-op Follow-up 
Fig. 7. Mean orolaryngeal resistance (R0i) in 11 patients operated on using the laterofixation 
procedure. 
2 n 
Pre-op Post-op Follow-up 
Fig. 8. Mean FIVj in 7 patients with bilateral vocal cord paralysis operated on using the 
laterofixation procedure. 
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The spirometry was evaluated in only 7 patients. No statistically significant differences 
were found. FIVi was preoperative!y found to be 1.3 ± 0.1 1 (SEM) and at both 
postoperative measurements FTVi was 1.7 ± 0.2 1 (Fig. 8). Only minor changes were 
noticed regarding FEV i and the FEV l/FIV \ quotient. Four patients were not evaluated 
regarding spirometry. Two patients could not perform satisfactory spirometry tests on all 
three occasions due to high age and/or neurological disorders. An early postoperative 
spirometry was missing in one patient. Finally, a partial pulmonectomy, due to a 
neoplasm, was performed in one patient nine years postoperatively just but before the 
follow-up examination. 
Voice quality 
No significant differences of the voice regarding timbre, tempo or inspiratory stridor 
could be found between the first postoperative and the follow-up tape recordings. 94% of 
the first postoperative voice samples and 95% of the follow-up voice samples were 
socially acceptable according to the amateur panel. The corresponding figures for the 
speech therapist panel were 72% and 65%. 
Voice function has to be influenced by moving a vocal cord from a median or 
paramedian to a lateral position. An earlier report has shown that the laterofixation 
influences the voice quality negatively by increasing the phonatory leakage (122). 
However, the disturbances from the inspiratory stridor are reduced (122). The present 
study indicates that the voice quality does not change during the years after operation. 
Aspiration 
At the hypopharynx-esophagus radiographic examination with barium contrast, all 
investigated patients had normal function except one patient with a tendency to aspirate. 
This patient had a known stricture of the upper esophageal sphincter and in 1969, 
10 years before the laterofixation, aspiration was documented radiologically. According 
to this study, no patient has developed a tendency to aspirate after the operation. 
To our knowledge, these are the only documented long-term results after bilateral 
vocal cord surgery. Objective documentation has often been lacking. Breathing and voice 
quality have only been subjectively evaluated, or only commented on by a note as to 
whether the patients could be decannulated or not, and aspiration has in most cases not 
been discussed (123-132). Flow-volume loops and airway resistance assessed with a 
body-plethysinograph have in some studies been used but not R0j assessments (133-
135). 
The mobilization and laterofixation operation (V) 
No preoperative or postoperative complications occurred. Four of the 5 patients with 
tracheostomas preoperatively were decannulated within 14 days postoperatively. One 
patient failed to improve. The effects of the operation on respiration are summarized in 
Table 12. In 5 of 6 patients, inspiratory R01 decreased from an average of 1.1 kPa/(l/s) to 
an average of 0.4 kPa/(l/s). No patient developed any problems with aspiration. 
Four of the 5 female patients had earlier been tracheotomized under more or less 
emergency circumstances. Three of these patients had been admitted as emergency cases 
with inspiratory stridor, which in 2 of them was induced by an upper airway infection. 
The fourth patient could not be extubated after an operation on her cervical column and 
had to be tracheotomized. 
All 5 patients with tracheostomas needed hospital care before the operation. Patient 
no 2 had a very severe airway obstruction (Table 12). She was the only one not 
decannulated postoperatively. Two patients were able to return to their homes and another 
two were discharged to nursing homes postoperatively. The male patient with juvenile 
RA (no 1) continued working full time after the operation. 
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Table 12. Effects of the mobilization and laterofixation operation on respiration. 
Upper airway resistance 
(kPa/tl/s]) Tracheostomy 
Patient no Preop. Postop. Preop. Postop. 
1 
2 
3 
4 
5 
6 
10.0 
1.9 
0.7 
0.7 
1.5 
0.8 
0.8 
0.5 
0.3 
0.3 
0.2 No 
Yes 
Yes 
Yes 
Yes 
Yes 
No 
Yes 
No 
No 
No 
No 
The effects of the operation on the voice were difficult to document objectively because 
5 of the patients were tracheotomized preoperatively. The voice of the patient that was not 
tracheotomized was judged to be unchanged by the patient himself and by a speech 
therapist when listening to pre and postoperative tape recordings. All the decannulated 
patients had acceptable voices postoperatively, judged by themselves. 
Simple laterofixation of one vocal cord (122) was not sufficient to reduce the laryngeal 
obstruction. However, if the arytenoid cartilages were mobilized before laterofixation, the 
operation was feasible. The dilation did not cause any visible laryngeal edema or 
bleeding. 
Few procedures specifically intended for treating cricoarytenoid ankylosis have been 
presented. Montgomery described a method in which one arytenoid cartilage was 
removed and the vocal cord lateralized with a steel suture (15). The operation was 
performed via laryngofissure, preceded by tracheotomy. The effects of these procedures 
on breathing were not documented. With the present technique, no tissue is damaged, 
which allows any other second operation if necessary. The vocal cord laterofixation by 
our technique can be modified. If, for example, the voice has become aphonic, due to a to 
wide glottal rima, the loop can be released. On the other hand, the operation can also be 
repeated if the breathing has not improved sufficiently. 
In patients with severe RA, involvement of the cervical column is common. The neck 
must therefore be bent cautiously. In this series, a special vacuum pillow (Camp 
Scandinavia AB), which prevented bending of the neck, was used in 2 patients with 
subluxations between the first and second cervical vertebrae. Although an operation 
microscope or chest support for the laryngoscope was impossible to use in 4 patients, the 
operation could be performed with only minor added difficulties. Other endolaryngeal 
procedures for bilateral vocal cord paralysis would be difficult to perform without chest 
support and a microscope. 
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MAIN OBSERVATIONS AND CONCLUSIONS 
• Signs of laryngeal involvement were found in about two-thirds of the RA 
patients. 
• Voice problems were reported by 40% of patients with laryngeal involvement 
compared to none of the patients without laryngeal involvement. 
• Patients afflicted with RA had symptoms related to the esophagus and dry mouth 
four times more often than healthy controls. 
• Esophageal manometry revealed that the amplitude of the peristaltic pressure 
complex in the proximal part of the esophagus was significantly decreased in the 
RA group. 
• It seemed possible to detect a laryngeal obstruction and to some extent quantify 
the obstruction by CT. 
• The favourable postoperative results after vocal cord laterofixation according to 
Ejnell et al in patients with bilateral vocal cord paralysis were longlasting 
regarding breathing capacity and voice quality and no aspiration was evoked. 
• It was possible to operate upon RA patients with cricoarytenoid joint ankylosis 
with a new vocal cord mobilization and laterofixation procedure with good results. 
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